Injectables


TULANEXT 10

Treatment and metaphylaxis of bovine respiratory disease.

Active Substances

Each ml contains: tulathromycin 100 mg. 

Description

Treatment and metaphylaxis of bovine respiratory disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, Histophilus somni and Mycoplasma bovis sensitive to tulathromycin. The presence of the disease in the group must be established before the use of this medication. Treatment of infectious bovine keratoconjunctivitis (IKB) associated with tulathromycin-susceptible Moraxella bovis. Used for sheep treatment of the early stages of infectious pododermatitis (pedero) associated with virulent Dichelobacter nodosus requiring systemic treatment.

Usage

Target Species


Dosage


Withdrawal Period


What is next?

Found the products of your interest, do not hesitate to ask for a quotation. Contact us now.

Check other products by category

Medicals

Supplements

Injectables

Feed Additives

Intramammary

Disinfectants